Suppr超能文献

使用依维莫司治疗新生儿心脏横纹肌瘤和持续性心律失常:益处与并发症

Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications.

作者信息

Sagiv Eyal, Chikkabyrappa Sathish Mallenahalli, Conwell Jeffrey, Lewin Mark, Chun Terrence Un Hoong

机构信息

Division of Pediatric Cardiology, Seattle Children's Hospital and the University of Washington School of Medicine, Seattle, WA, USA.

出版信息

Ann Pediatr Cardiol. 2022 Jan-Feb;15(1):58-60. doi: 10.4103/apc.apc_11_21. Epub 2022 Jun 14.

Abstract

We report treating a term neonate with tuberous sclerosis and giant rhabdomyomas who presented with incessant supraventricular tachycardia with Everolimus. The treatment was efficient in reducing tumor size and assisted as an adjunct therapy in controlling arrhythmia and limiting preexcitation. Treatment was challenged by difficulty to achieve stable drug level and limited by neutropenia as a serious side effect.

摘要

我们报告了对一名患有结节性硬化症和巨大横纹肌瘤的足月儿使用依维莫司治疗,该患儿出现持续性室上性心动过速。该治疗在缩小肿瘤大小方面有效,并作为辅助治疗有助于控制心律失常和限制预激。治疗面临难以达到稳定药物水平的挑战,且受到严重副作用中性粒细胞减少的限制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a916/9280109/faeddeaef348/APC-15-58-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验